By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Benzodiazepine > Alprazolam

Alprazolam

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|676 words

What is Alprazolam?

Alprazolam is a prescription medication belonging to the benzodiazepine class of drugs, which work by depressing the central nervous system. It is primarily prescribed to treat anxiety disorders and panic disorder, providing rapid relief from symptoms of excessive worry, fear, and panic attacks. Due to its potential for dependence and abuse, alprazolam is classified as a controlled substance and requires careful medical supervision.

Uses

Alprazolam is FDA-approved for several specific conditions:

  • Generalized Anxiety Disorder (GAD): Helps manage excessive worry, restlessness, and physical symptoms of anxiety that interfere with daily functioning
  • Panic Disorder: Reduces the frequency and intensity of panic attacks, including symptoms like rapid heartbeat, sweating, and feelings of impending doom
  • Anxiety associated with depression: May be prescribed short-term to help manage anxiety symptoms that occur alongside depressive disorders
  • Situational anxiety: Sometimes used for brief periods to manage anxiety related to specific stressful events or medical procedures
  • Agoraphobia: May help individuals with panic disorder who also experience fear of being in situations where escape might be difficult

How it works

Alprazolam enhances the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that naturally calms brain activity by inhibiting nerve transmission. By binding to specific GABA receptors in the brain, alprazolam increases GABA’s calming effects, resulting in reduced anxiety, muscle relaxation, and sedation. This mechanism provides relatively quick relief from anxiety symptoms, typically within 30 minutes to an hour of taking the medication.

Side effects

Common side effects:

Submit Your Paper
GMJ_Submit_Banner
  • Drowsiness and sedation
  • Dizziness and lightheadedness
  • Fatigue and weakness
  • Memory problems and confusion
  • Slurred speech
  • Loss of coordination
  • Dry mouth
  • Changes in appetite

Serious side effects requiring immediate medical attention:

  • Severe respiratory depression or difficulty breathing
  • Loss of consciousness or extreme sedation
  • Severe confusion or memory loss
  • Signs of allergic reaction (rash, swelling, difficulty breathing)
  • Suicidal thoughts or unusual mood changes

Warnings and precautions

  • Dependence and withdrawal: Alprazolam can cause physical dependence even when used as prescribed. Sudden discontinuation can lead to dangerous withdrawal symptoms including seizures
  • Pregnancy and breastfeeding: Classified as FDA pregnancy category D, meaning it may harm an unborn baby. It also passes into breast milk and can affect nursing infants
  • Respiratory conditions: Should be avoided in patients with severe respiratory impairment, sleep apnea, or other breathing disorders due to risk of respiratory depression
  • Liver impairment: Patients with liver disease may need dose adjustments as the medication is metabolized by the liver
  • Elderly patients: Older adults are more sensitive to benzodiazepines and face increased risk of falls, confusion, and cognitive impairment

Interactions

  • Alcohol: Dangerous combination that can cause severe sedation, respiratory depression, and potentially fatal overdose
  • Opioid medications: Concurrent use significantly increases risk of respiratory depression, coma, and death
  • Other CNS depressants: Barbiturates, sleep medications, and muscle relaxants can amplify sedative effects
  • Antifungal medications: Ketoconazole and itraconazole can increase alprazolam levels by inhibiting its metabolism
  • Certain antidepressants: Fluoxetine and fluvoxamine may increase alprazolam concentrations in the blood
  • Grapefruit juice: Can increase absorption of alprazolam, leading to enhanced effects and side effects
  • Anticonvulsants: Carbamazepine and phenytoin may reduce alprazolam effectiveness by increasing its metabolism
  • St. John’s Wort: This herbal supplement may decrease alprazolam levels and reduce its effectiveness

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary based on the condition being treated and individual patient factors. For anxiety disorders, the usual starting dose is 0.25 to 0.5 mg taken three times daily, with gradual increases as needed up to a maximum of 4 mg daily in divided doses. For panic disorder, starting doses may be 0.5 mg three times daily, potentially increased to 1-10 mg daily in divided doses based on response and tolerance. Extended-release formulations are typically started at 0.5-1 mg once daily in the morning. Elderly patients generally require lower doses due to increased sensitivity. All dosage adjustments should be made gradually under medical supervision, and the lowest effective dose should be used for the shortest duration possible.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Alprazolam." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/alprazolam/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Evidence review: Which supplements older adults actually need and which ones to avoid

New evidence shows older adults benefit more from targeted supplementation for specific…

Traditional Chinese herb shows promise for androgenetic alopecia treatment

Traditional Chinese herb Polygonum multiflorum shows promise for treating androgenetic alopecia through…

Dual Doctor Couples Face Amplified Childcare Crisis in Medical Training

Dual doctor couples face amplified childcare challenges during medical training, with foundation…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Lorazepam

By
Prof. Giorgi Pkhakadze
02/06/2026

Clonazepam

By
Prof. Giorgi Pkhakadze
02/06/2026

Midazolam

By
Prof. Giorgi Pkhakadze
02/06/2026

Diazepam

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up